The rates are remarkably similar across all three, despite their different mechanisms: Semaglutide: Nausea approximately 18%, diarrhea approximately 12%, vomiting approximately 8% Tirzepatide: Nausea 17-22% (dose dependent), diarrhea 13-16%, vomiting 6-10% Retatrutide: Nausea 16-25% (dose dependent), diarrhea 15-22%, vomiting 8-13% The pattern holds consistently
Control group An age-appropriate group of neurotypical children meeting the predefined eligibility criteria was recruited as healthy controls and included in the metabolomic analyses
The difference lies in cost: compounded semaglutide is $189/mo month-to-monthnth through PlexusDx, while brand Ozempic costs $900$1,400 even with insurance
The nutrients are complexed with aspartic acid in free form to support muscle, nerve, and cellular function
Metabolic health improvements Blood sugar control: HbA1c reductions of 12% are typical, even in non-diabetic patients with elevated baseline blood sugar Blood pressure: Average systolic reductions of 36 mmHg observed across major trials Lipid profile: Meaningful reductions in triglycerides
There are so many people out there that are suffering, and they dont need to be
